172 related articles for article (PubMed ID: 36868225)
1. Cancer cachexia: involvement of an expanding macroenvironment.
Pryce BR; Wang DJ; Zimmers TA; Ostrowski MC; Guttridge DC
Cancer Cell; 2023 Mar; 41(3):581-584. PubMed ID: 36868225
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management.
Argilés JM; López-Soriano FJ; Stemmler B; Busquets S
Nat Rev Clin Oncol; 2023 Apr; 20(4):250-264. PubMed ID: 36806788
[TBL] [Abstract][Full Text] [Related]
3. mTOR and Tumor Cachexia.
Duval AP; Jeanneret C; Santoro T; Dormond O
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061533
[TBL] [Abstract][Full Text] [Related]
4. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
5. Nonmuscle Tissues Contribution to Cancer Cachexia.
Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
Mediators Inflamm; 2015; 2015():182872. PubMed ID: 26523094
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
Dolly A; Dumas JF; Servais S
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604
[TBL] [Abstract][Full Text] [Related]
7. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
8. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
10. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Prado CM; Sawyer MB; Ghosh S; Lieffers JR; Esfandiari N; Antoun S; Baracos VE
Am J Clin Nutr; 2013 Oct; 98(4):1012-9. PubMed ID: 23966429
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies.
Martin A; Freyssenet D
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):252-273. PubMed ID: 33783983
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
Asp ML; Tian M; Kliewer KL; Belury MA
Cancer Biol Ther; 2011 Dec; 12(11):957-65. PubMed ID: 22104958
[TBL] [Abstract][Full Text] [Related]
13. β-Hydroxy-β-methylbutyrate as a countermeasure for cancer cachexia: a cellular and molecular rationale.
Kim JS; Khamoui AV; Jo E; Park BS; Lee WJ
Anticancer Agents Med Chem; 2013 Oct; 13(8):1188-96. PubMed ID: 23919746
[TBL] [Abstract][Full Text] [Related]
14. Understanding cachexia in the context of metastatic progression.
Biswas AK; Acharyya S
Nat Rev Cancer; 2020 May; 20(5):274-284. PubMed ID: 32235902
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
Shukla SK; Dasgupta A; Mulder SE; Singh PK
Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
[TBL] [Abstract][Full Text] [Related]
16. Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation.
Daou N; Hassani M; Matos E; De Castro GS; Costa RGF; Seelaender M; Moresi V; Rocchi M; Adamo S; Li Z; Agbulut O; Coletti D
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041358
[TBL] [Abstract][Full Text] [Related]
17. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
[TBL] [Abstract][Full Text] [Related]
18. Drosophila as a Model for Tumor-Induced Organ Wasting.
Saavedra P; Perrimon N
Adv Exp Med Biol; 2019; 1167():191-205. PubMed ID: 31520356
[TBL] [Abstract][Full Text] [Related]
19. The Adipokines in Cancer Cachexia.
Mannelli M; Gamberi T; Magherini F; Fiaschi T
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660156
[TBL] [Abstract][Full Text] [Related]
20. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.
He WA; Calore F; Londhe P; Canella A; Guttridge DC; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4525-9. PubMed ID: 24616506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
